Literature DB >> 15569159

Id2 haploinsufficiency in mice leads to congenital hydronephrosis resembling that in humans.

Yoshitaka Aoki1, Seiichi Mori, Kazuhito Kitajima, Osamu Yokoyama, Hiroshi Kanamaru, Kenichiro Okada, Yoshifumi Yokota.   

Abstract

Congenital hydronephrosis is one of the most common anomalies found in humans and may cause renal failure in childhood. Half of the cases are due to obstruction at the ureteropelvic junction (UPJ). Here we report that mice lacking Id2, an inhibitor of basic helix-loop-helix (bHLH) transcription factors, exhibit hydronephrosis mimicking the characteristics of human cases such as unilaterality and male preponderance. Hydronephrosis was found even in Id2+/- mice. The penetrance was 67.2% in Id2-/- males, 48.8% in Id2+/- males, 28.0% in Id2-/- females and 20.0% in Id2+/- females. Distortion or high insertion of the ureter at the UPJ was frequently observed and these morphological changes were evident in late embryogenesis. Histologically, the muscle layer, where Id2 is normally expressed, was hypertrophic and/or irregular at the UPJ. Furthermore, gene expression analysis suggested that BMP4 (bone morphogenetic protein 4), which is known to be involved in the development of hydronephrosis, appears to function as an upstream factor of Id2. Our results thus raise the possibility that Id2 is a gene responsible for the pathogenesis of hydronephrosis in man.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569159     DOI: 10.1111/j.1365-2443.2004.00805.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  18 in total

1.  Absence of canonical Smad signaling in ureteral and bladder mesenchyme causes ureteropelvic junction obstruction.

Authors:  Piyush Tripathi; Yinqiu Wang; Adam M Casey; Feng Chen
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 2.  Pathophysiology and treatment of ureteropelvic junction obstruction.

Authors:  Brent Williams; Basir Tareen; Martin I Resnick
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

Review 3.  Genetic and developmental basis for urinary tract obstruction.

Authors:  Feng Chen
Journal:  Pediatr Nephrol       Date:  2008-12-16       Impact factor: 3.714

Review 4.  Vesicoureteric reflux and reflux nephropathy: from mouse models to childhood disease.

Authors:  Marie-Lyne Fillion; Christine L Watt; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2014-02-06       Impact factor: 3.714

5.  Mutation screening of BMP4 and Id2 genes in Chinese patients with congenital ureteropelvic junction obstruction.

Authors:  Jun Li He; Jun Hong Liu; Feng Liu; Ping Tan; Tao Lin; Xu Liang Li
Journal:  Eur J Pediatr       Date:  2011-09-17       Impact factor: 3.183

6.  Hspa4l-deficient mice display increased incidence of male infertility and hydronephrosis development.

Authors:  Torsten Held; Ilona Paprotta; Janchiv Khulan; Bernhardt Hemmerlein; Lutz Binder; Stephan Wolf; Stephanie Schubert; Andreas Meinhardt; Wolfgang Engel; Ibrahim M Adham
Journal:  Mol Cell Biol       Date:  2006-08-21       Impact factor: 4.272

7.  Midline signaling regulates kidney positioning but not nephrogenesis through Shh.

Authors:  Piyush Tripathi; Qiusha Guo; Yinqiu Wang; Matthew Coussens; Helen Liapis; Sanjay Jain; Michael R Kuehn; Mario R Capecchi; Feng Chen
Journal:  Dev Biol       Date:  2010-02-10       Impact factor: 3.582

8.  Transgenic overexpression of p23 induces spontaneous hydronephrosis in mice.

Authors:  Jaehoon Lee; Hye Jin Kim; Jung Ah Moon; Young Hoon Sung; In-Jeoung Baek; Jae-il Roh; Na Young Ha; Seung-Yeon Kim; Young Yil Bahk; Jong Eun Lee; Tae Hyun Yoo; Han-Woong Lee
Journal:  Int J Exp Pathol       Date:  2011-02-16       Impact factor: 1.925

Review 9.  Lower urinary tract development and disease.

Authors:  Hila Milo Rasouly; Weining Lu
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-02-13

10.  Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection.

Authors:  Kangsun Yun
Journal:  J Vis Exp       Date:  2017-10-12       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.